课题基金 / 基金详情

STAT in TNF alpha induced Apoptosis

STAT in TNF alpha induced Apoptosis
STAT 在 TNF α 诱导的细胞凋亡中的作用
批准号:
6812631
负责人:
Y. Eugene Chin
金额:
$24.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-03-01 至 2005-02-28

项目摘要

项目成果

Y. Eugene Chin的其他基金

相似基金

相关文献

中文摘要
翻译
肿瘤坏死因子-a(TNFa),一种多效细胞因子, 从激活的巨噬细胞和其他细胞,在一些 炎症、心血管和全身性疾病。TNFa是一种潜在的 抗癌剂。然而,TNFa对细胞具有双重但相反的作用, 生长/存活:在某些癌细胞中抑制生长并诱导凋亡 而是刺激生长并维持其他物种的生存。通过与细胞结合 表面受体(TNFR1/TNFR2),TNJFa激发若干信号传导事件 包括半胱天冬酶级联和NF-κ B的活化。半胱天冬酶激活或 该途径的组分的过度表达通常导致细胞凋亡。在 相反,NF-κ B活化对于促进细胞存活至关重要, 抑制细胞凋亡。因此,TNF α在细胞上的输出取决于平衡 NF-κ B和Caspase激活之间的关系。为了触发细胞凋亡,TNF α不仅需要 激活胱天蛋白酶,而且使NF-κ B激活最小化甚至关闭。 关于TNFa如何抑制NF-xB激活,同时触发 半胱天冬酶激活。蛋白质酪氨酸磷酸化在信号中的作用 已经证实了许多细胞因子的转导,但对于 TNF α。JAK(Janus激酶)-STAT(信号转导和激活因子) 转录)途径是酪氨酸磷酸化信号传导途径, 干扰素和其它细胞因子。几条证据表明JAK/STAT 可能在TNF α的信号传导中起重要作用。首先,TNF受体 招募JAK/Stati,特别是在TNF α敏感细胞中。第二,贾基和 Stati-deficient细胞变得具有TNF α抗性。三、TNFR1信令适配器 TRADD转染诱导的细胞凋亡通过与 斯塔蒂这些发现导致了以下工作假设: 与TNFR1/TRADD复合物相关的信号衔接子。它有利于TNF α诱导的 通过稳定死亡信号复合物的形成和抑制 NF-κ B活化及其随后的基因调控。在拟议的研究中, 具体目标是设计利用这些新信息如下:(1) 肿瘤坏死因子受体介导的JAK/Stat1激活和Stati作为信号衔接子的作用 将检测死亡信号转导。(2)之间的相互作用 Stati和TRADD稳定死亡信号复合物(TNFR1-TRADD-FADD) 将分析形成。(3)Stati对NF-κ B介导的抑制作用 基因调控将进一步探索。这些补充办法将 阐明Stati在TNa诱导细胞凋亡中的基本作用, 最终会促进癌症治疗的发展。
英文摘要
Tumor necrosis factor-a (TNFa), a pleiotropic cytokine derived from activated macrophages and other cells, plays pivotal roles in some inflammatory, cardiovascular, and systemic diseases. TNFa is a potential anticancer agent. However, TNFa has dual but opposing effects on cell growth/survival: it inhibits growth and induces apoptosis in some cancer cells but stimulates growth and maintains survival in others. By binding to its cell surface receptors (TNFR1/TNFR2), TNJFa elicits several signaling events including activation of the Caspase cascade and NF-KB. Caspase activation or over-expression of a component(s) of this pathway often leads to apoptosis. In contrast, NF-KB activation is critical for promoting cell survival and suppressing apoptosis. Thus, TNFa's output on cell is decided by the balance between NF-KB and Caspase activation. To trigger apoptosis, TNFa needs not only to activate Caspases but also to minimize or even shut down NF-KB activation. Little is known about how TNFa suppresses NF-xB activation while triggering Caspase activation. The role of protein tyrosine phosphorylation in signal transduction has been confirmed for many cytokines but remains unclear for TNFa. The JAK (Janus kinase)-STAT (signal transducer and activator of transcription) pathway is a tyrosine phosphorylation-signaling route used by interferon and other cytokines. Several lines of evidence suggest that JAK/STAT may play an important role in TNFa's signaling events. First, TNF receptors recruit JAK/Stati especially in TNFa-sensitive cells. Second, both Jaki- and Stati-deficient cells become TNFa resistant. Third, TNFR1 signaling adapter TRADD transfection-induced apoptosis is sensitized by co-transfection with Stati. These findings lead to the following working hypothesis: phosphoStati is a signal adapter associated with TNFR1/TRADD complex. It favors TNFa-induced cell death by stabilizing the death signaling complex formation and inhibiting NF-kB activation and its subsequent gene regulation. In the proposed study, the specific aims are designed to exploit this new information as follows: (1) TNFR-mediated JAK/Stat 1 activation and the role of Stati as a signal adapter in death signal transduction will be examined. (2) The interaction between Stati and TRADD in stabilizing death-signaling complex (TNFR1-TRADD-FADD) formation will be analyzed. (3) The inhibitory role of Stati on NF-KB-mediated gene regulation will be further explored. These complimentary approaches will elucidate the fundamental role of Stati in apoptosis induction by TNa and might eventually provide a boost to cancer therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACETYLATION DEPENDENT STAT3 SIGNALSOME IN LIVER CANCER
  • 批准号:
    8359718
  • 项目类别:
  • 资助金额:
    $5.18万
  • 财政年份:
    2011
  • 负责人:
    Y. Eugene Chin
  • 依托单位:
ACETYLATION DEPENDENT STAT3 SIGNALOSOME IN LIVER CANCER
  • 批准号:
    8167905
  • 项目类别:
  • 资助金额:
    $20.69万
  • 财政年份:
    2010
  • 负责人:
    Y. Eugene Chin
  • 依托单位:
Acetylation-Dependent IFN Signal Transduction
  • 批准号:
    7944147
  • 项目类别:
  • 资助金额:
    $29.81万
  • 财政年份:
    2009
  • 负责人:
    Y. Eugene Chin
  • 依托单位:
STAT3 Acetylation and Deacetylation in Metastasis
  • 批准号:
    7234439
  • 项目类别:
  • 资助金额:
    $28.09万
  • 财政年份:
    2005
  • 负责人:
    Y. Eugene Chin
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: